The state health department stated that the company has officially closed following investigations into toxic contaminants, specifically diethylene glycol (DEG), in their cough syrup, Coldrif.
The Tamil Nadu Drugs Control Department on Monday announced the cancellation of the manufacturing license of Sresan Pharmaceutical company, maker of Coldrif cough syrup, in connection with the death of at least 22 people in Madhya Pradesh.
The state health department stated that the company has officially closed following investigations into toxic contaminants, specifically diethylene glycol (DEG), in their cough syrup, Coldrif.
Moreover, the department has ordered comprehensive inspections at all pharmaceutical manufacturing units in Tamil Nadu and large-scale inspections are currently underway across the state.
A court in Parasia sent Sresan Pharma owner Ranganathan to ten days of police custody after he was arrested in Chennai on October 9 by a SIT from Madhya Pradesh.
Two senior drug inspectors have also been suspended for dereliction of duty. The Tamil Nadu government has ordered extensive inspections of other pharmaceutical manufacturing companies in the state.
Earlier, BJP leader K Annamalai criticized the Tamil Nadu government for its handling of a case. He highlighted that the state government has suspended only two drug inspectors after the Special Investigation Team (SIT) intervened and accused the TN government of creating an “illusion” and evading responsibility.
“A drug manufactured by a private pharmaceutical company in Kanchipuram has reportedly caused the deaths of 23 people in Madhya Pradesh and three children in Rajasthan. However, the Tamil Nadu government has suspended only two drug inspectors and is trying to create the illusion that it has no nexus or responsibility in the matter. Yesterday, the Drugs Controller General of India (DCGI) made an important decision. This time, the agency has decided that every drug manufactured in India must undergo mandatory testing before being approved,” he said.
He also noted the company’s history of quality violations and lack of inspections by Tamil Nadu drug inspectors.
Moreover, the Drugs Controller General of India (DCGI) has issued a directive to all states and Union Territories, calling for strict compliance with the Drugs and Cosmetics Rules, 1945 for testing of raw materials and finished pharmaceutical formulations.
(Except for the headline, this story has not been edited by DNA staff and published by ANI)
#BAD #news #Coldrif #maker #Tamil #Nadu #drug #control #department #CANCELS #Sresan #Pharmaceuticals #license #closes #company